Skip to content
Research Article Open access CC BY 4.0

Evaluation of the Biological Response to Acetylsalicylic Acid by Platelet Occlusion Time in Pregnant Women in Brazzaville

LT Ocko Gokaba, JA Elira Samba, OF Galiba Atipo-Tsiba, GRJ Buambo, LO Ngolet, RC Iwandza, P Issongo Amboulou, J Nziengui Mboumba, C Bango, C Itoua, A Elira Dokekias

International Blood Research & Reviews · pp. 18–25 · Published 29 Jan 2024

10.9734/ibrr/2024/v15i1331

Abstract

Low-dose acetylsalicylic acid (ASA) has been recommended for pregnant women since 2011 by the OMS to prevent thrombotic phenomena. Despite the variability of its clinical efficacy (resistance phenomena), its non-standardized biological monitoring can be performed using platelet occlusion time (POT). The aim of this study was to assess the response to ASA using POT. A multicenter, cross-sectional, analytical study was conducted in the obstetrics and gynaecology departments of six Brazzaville hospitals over a period of 09 months and included pregnant women on ASA 100 mg daily for at least 7 days. POT was measured using the INNOVANCE® PFA®-200 system. The variables studied were clinical (age, medical and obstetrical history) and biological (blood count, POT). Non-response to ASA was defined by a POT of 150 seconds or less. Data analysis was performed using STATA 12 software. Logistic regression was used to assess the determinants associated with non-response. The incidence of obstetric complications according to ASA resistance was evaluated by the Kaplan-Meier method and the Log-Rank test. The significance threshold was p<0.005. The study involved 39 pregnant women, mean age 33.9 ± 5.4 years, treated with ASA for hypertensive disorders of pregnancy n=19 (48.7%), chronic arterial hypertension n=7 (18%), diabetes n=3(7.7%) fetal death n=3(7.7%), unexplained miscarriage n=3(7.7%), advanced age n=2 (5.1%) and twin pregnancy n=2(5.1%). The median body index was 25.5 kg/m2 [23.7;29.4] with 35.9% women of normal weight, 48.7% overweight and 15.4% obese. Non-response to ASA was found in 12 pregnant women (30.7%). No statistically significant differences were observed between non-responders and responders with regard to epidemiological, clinical and haematological determinants (p>0.05). Non-response was more observed in women with complications 23.08% versus 7.7% (p=0,008). Non-response to ASA, present in a third of hypertensive pregnant women, is associated with the occurrence of obstetrical complications in Brazzaville.

pregnancy acetylsalicylic acid PFA-200 biological response

References (15)

  1. 1 Profile and prevalence of aspirin resistance in patients with cardiovascular disease [DOI]
  2. 2 Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus [DOI]
  3. 3 A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease [DOI]
  4. 4 Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway [DOI]
  5. 5 Clinical utility of closure times using the platelet function analyzer‐100/200 [DOI]
  6. 6 Platelets in pregnancy: hyperdestruction in pregnancy.
  7. 7 Low-dose ASA Response Using the PFA-100 in Women With High-risk Pregnancy [DOI]
  8. 8 Is testing for aspirin response worthwhile in high-risk pregnancy? [DOI]
  9. 9 Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia [DOI]
  10. 10 Resistance of aspirin during and after pregnancy: A longitudinal cohort study [DOI]
  11. 11 Aspirin non-response in pregnant women at increased risk of pre-eclampsia [DOI]
  12. 12 Vasoactive substances Nitric oxide and endothelial dysfunction in atherosclerosis [DOI]
  13. 13 Advances in Platelet Counting [DOI]
  14. 14 Reduced plasma membrane Ca2+-ATPase function in platelets from patients with non-insulin-dependent diabetes mellitus.
  15. 15 379 Comparison of different methods to evaluate the effect of aspirin on platelet function in patients with coronary artery disease [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

27

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.